Safety profile and signal detection of phosphodiesterase type 5 inhibitors for erectile dysfunction: a Food and Drug Administration Adverse Event Reporting System analysis

BACKGROUND: Phosphodiesterase type 5 inhibitors (PDE5Is) are generally well tolerated but have been associated with uncommon and significant adverse events (AEs). AIM: This study aims to investigate and compare the characteristics of AEs associated with PDE5Is used for erectile dysfunction and ident...

Descripción completa

Detalles Bibliográficos
Autores principales: Shin, Young Eun, Rojanasarot, Sirikan, Hincapie, Ana L, Guo, Jeff Jianfei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Pharmacotherapy
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10687329/
https://www.ncbi.nlm.nih.gov/pubmed/38034088
http://dx.doi.org/10.1093/sexmed/qfad059

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10687329/
https://www.ncbi.nlm.nih.gov/pubmed/38034088
http://dx.doi.org/10.1093/sexmed/qfad059

Ejemplares similares